Matches in Nanopublications for { ?s ?p "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP286614.RAdxljt4cKaEn7UE0gvotG_kiVAm-eXCauULWqK7-AVIU130_assertion description "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286614.RAdxljt4cKaEn7UE0gvotG_kiVAm-eXCauULWqK7-AVIU130_provenance.
- NP615055.RAYC10juwnPF0HbvaIuIkP4Nqg8pkSYOVfSUtYVU9Gzjs130_assertion description "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615055.RAYC10juwnPF0HbvaIuIkP4Nqg8pkSYOVfSUtYVU9Gzjs130_provenance.
- NP502006.RA_Bkgy4fqO1RF9h4-eq0q48uYWjPKidSh-oYbNsSgrIs130_assertion description "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502006.RA_Bkgy4fqO1RF9h4-eq0q48uYWjPKidSh-oYbNsSgrIs130_provenance.
- NP376237.RAPLqmkge310FlQkm0NGQymKh_hetenAZLhSeEmyCk7IE130_assertion description "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376237.RAPLqmkge310FlQkm0NGQymKh_hetenAZLhSeEmyCk7IE130_provenance.
- NP924685.RAU1f77bmO_tBqHyRrBJEQXxgKKiZb63KpwLguQIi3QbI130_assertion description "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924685.RAU1f77bmO_tBqHyRrBJEQXxgKKiZb63KpwLguQIi3QbI130_provenance.
- assertion description "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1092013.RA2kLDwfixW0CZT_GoTmQnbDGKYtuVPJ2K0HK1HTkc8ik130_assertion description "[Together, our results indicate that C1GALT1 overexpression in hepatocellular carcinoma activates HGF signaling via modulation of MET O-glycosylation and dimerization, providing new insights into how O-glycosylation drives hepatocellular carcinoma pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092013.RA2kLDwfixW0CZT_GoTmQnbDGKYtuVPJ2K0HK1HTkc8ik130_provenance.